Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fielding

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Clinical Radiology|June 12, 2014
N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?K G Foley, W G Lewis, P Fielding, et al.
Cancer Research|August 17, 2000
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomasG Xinarianos, T Liloglou, W Prime, et al.
Clinical Radiology|September 18, 2012
Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancerD S Y Chan, P Fielding, S A Roberts, et al.
BMJ (Clinical Research Ed.)|February 4, 1995
Severe gastroparesis diabeticorum in a young patient with insulin dependent diabetesC J Dowling, S Kumar, J M Boulton, et al.
The Journal of Surgical Research|January 1, 1995
PYY inhibition of VIP-stimulated ion transport in the rabbit distal ileumJ A Quin, S A Sgambati, J R Goldenring, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2018
Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancerN Patel, Kieran G Foley, A G Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
The evolution of loss of heterozygosity on chromosome 17 during the progression to barrett's adenocarcinoma involves a unique combination of target sites in individual specimensJ R Dunn, J Garde, K Dolan, et al.
The American Journal of Physiology|May 1, 1993
Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colonG H Ballantyne, J R Goldenring, F X Fleming, et al.
Archives of Pathology & Laboratory Medicine|July 11, 2000
College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference ParticipantsM E Hammond, P L Fitzgibbons, C C Compton, et al.
American Journal of Surgery|January 1, 1989
Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?M D Basson, L P Fielding, A J Bilchik, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Clinical Radiology|June 12, 2014
N-staging of oesophageal and junctional carcinoma: is there still a role for EUS in patients staged N0 at PET/CT?K G Foley, W G Lewis, P Fielding, et al.
Cancer Research|August 17, 2000
hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomasG Xinarianos, T Liloglou, W Prime, et al.
Clinical Radiology|September 18, 2012
Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancerD S Y Chan, P Fielding, S A Roberts, et al.
BMJ (Clinical Research Ed.)|February 4, 1995
Severe gastroparesis diabeticorum in a young patient with insulin dependent diabetesC J Dowling, S Kumar, J M Boulton, et al.
The Journal of Surgical Research|January 1, 1995
PYY inhibition of VIP-stimulated ion transport in the rabbit distal ileumJ A Quin, S A Sgambati, J R Goldenring, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 18, 2018
Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancerN Patel, Kieran G Foley, A G Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
The evolution of loss of heterozygosity on chromosome 17 during the progression to barrett's adenocarcinoma involves a unique combination of target sites in individual specimensJ R Dunn, J Garde, K Dolan, et al.
The American Journal of Physiology|May 1, 1993
Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colonG H Ballantyne, J R Goldenring, F X Fleming, et al.
Archives of Pathology & Laboratory Medicine|July 11, 2000
College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation. Cancer Committee and Conference ParticipantsM E Hammond, P L Fitzgibbons, C C Compton, et al.
American Journal of Surgery|January 1, 1989
Does vasoactive intestinal polypeptide mediate the pathophysiology of bowel obstruction?M D Basson, L P Fielding, A J Bilchik, et al.
Pageof 14